Pheochromocytoma risk factors: Difference between revisions
Ifrah Fatima (talk | contribs) No edit summary |
Ifrah Fatima (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pheochromocytoma}} | {{Pheochromocytoma}} | ||
{{CMG}}; {{AE}} {{MAD}} | {{CMG}}; {{AE}} {{MAD}} {{IF}} | ||
==Overview== | ==Overview== | ||
| Line 11: | Line 11: | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of pheochromocytoma include: | *Common risk factors in the development of pheochromocytoma include harboring the following genes: | ||
**[[RET gene|RET]] gene ([[MEN, type 2a|MEN 2A]], [[Multiple endocrine neoplasia type 2|MEN 2B]] [[Syndrome|syndromes]]) | **[[RET gene|RET]] gene ([[MEN, type 2a|MEN 2A]], [[Multiple endocrine neoplasia type 2|MEN 2B]] [[Syndrome|syndromes]]) | ||
**[[NF1|NF1 gene]] | **[[NF1|NF1 gene]] | ||
| Line 18: | Line 18: | ||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of pheochromocytoma include: | *Less common risk factors in the development of pheochromocytoma include harboring the following genes: | ||
**[[SDHA]] | **[[SDHA]] | ||
**[[SDHAF2]] | **[[SDHAF2]] | ||
| Line 28: | Line 28: | ||
** [[MDH1|MDH2]] (malate dehydrogenase) | ** [[MDH1|MDH2]] (malate dehydrogenase) | ||
** KIF1Bß (kinesin family member) genes. <ref>{{cite book | last = Jameson | first = J | title = Harrison's Principles of Internal Medicine 19th Edition and Harrison's Manual of Medicine 19th Edition VAL PAK | publisher = McGraw-Hill Medical | location = New York | year = 2017 | isbn = 978-1260128857 }} </ref> | ** KIF1Bß (kinesin family member) genes. <ref>{{cite book | last = Jameson | first = J | title = Harrison's Principles of Internal Medicine 19th Edition and Harrison's Manual of Medicine 19th Edition VAL PAK | publisher = McGraw-Hill Medical | location = New York | year = 2017 | isbn = 978-1260128857 }} </ref> | ||
==References== | ==References== | ||
Revision as of 00:31, 25 July 2020
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma risk factors On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma risk factors |
|
Risk calculators and risk factors for Pheochromocytoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2] Ifrah Fatima, M.B.B.S[3]
Overview
The most potent risk factor for pheochromocytoma is a family history of multiple endocrine neoplasias, Von Hippel-Lindau disease, neurofibromatosis type 1, hereditary paraganglioma syndromes.
Risk Factors
The most potent risk factor in the development of pheochromocytoma is a family history of multiple endocrine neoplasias, Von Hippel-Lindau disease, neurofibromatosis type 1, hereditary paraganglioma syndromes.
Common Risk Factors
- Common risk factors in the development of pheochromocytoma include harboring the following genes:
Less Common Risk Factors
- Less common risk factors in the development of pheochromocytoma include harboring the following genes:
References
- ↑ Gimm O (2005). "Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx". Fam Cancer. 4 (1): 17–23. doi:10.1007/s10689-004-5740-1. PMID 15883706.
- ↑ Jameson, J (2017). Harrison's Principles of Internal Medicine 19th Edition and Harrison's Manual of Medicine 19th Edition VAL PAK. New York: McGraw-Hill Medical. ISBN 978-1260128857.